← Leaderboards
Sanjiv B Amin
University Of Rochester
$3,191,171
Attributed
$3,191,171
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $653.7K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,191,171 · 6
By mechanism
R01$1,293,392 · 1
K23$965,565 · 1
R21$759,783 · 2
R03$152,818 · 1
M01$19,613 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Mahin D. Maines$9,697,031
- Matthew D Liptak$2,989,145
- Daniel A Hammer$18,014,094
Others in their field
Top investigators on “Auditory”
- Daniel C. Javitt · New York University School Of Medicine$30,055,789
- Xiaoqin Wang · Johns Hopkins University$23,030,735
- Ebenezer N. Yamoah · University Of Nevada Reno$22,916,082
- Ulrich Mueller · Johns Hopkins University$21,603,938
- Karen J Cruickshanks · University Of Wisconsin Madison$21,351,137
- Edward Chang · University Of California, San Francisco$20,845,633
Research focus
AuditoryInfantSerumUniversitiesIcterusPrevalenceAcuteLaboratoriesToxic EffectMedical CenterEvaluationAlbuminsBaseCohortBilirubinHyperbilirubinemiaCostRisk FactorsNeuropathyIncidenceMorbidity - Disease RateBinding (Molecular Function)Gestational AgeProspective Studies
Grant awards (16)
Improving Brain Myelination with Iron (Fe) Supplementation in Term Infants with Perinatal Latent Iron Deficiency: A Double-Blind, Randomized, Placebo-Controlled Trial$1
R01 · FY2021 · NS · contact PI
Improving Brain Myelination with Iron (Fe) Supplementation in Term Infants with Perinatal Latent Iron Deficiency: A Double-Blind, Randomized, Placebo-Controlled Trial$639,701
R01 · FY2020 · NS · contact PI
Improving Brain Myelination with Iron (Fe) Supplementation in Term Infants with Perinatal Latent Iron Deficiency: A Double-Blind, Randomized, Placebo-Controlled Trial$653,690
R01 · FY2019 · NS · contact PI
Is Jaundice in Premature Infants a Risk Factor for Autism?$224,493
R21 · FY2015 · HD · contact PI
Is Jaundice in Premature Infants a Risk Factor for Autism?$191,875
R21 · FY2014 · HD · contact PI
Enamel Hypoplasia and Early Childhood Caries in Preterms with Jaundice$191,194
R21 · FY2011 · DE · contact PI
Enamel Hypoplasia and Early Childhood Caries in Preterms with Jaundice$152,221
R21 · FY2010 · DE · contact PI
Predicting Bilirubin-induced Auditory Toxicity in Infants with Severe Jaundice$75,818
R03 · FY2010 · HD · contact PI
Predicting Bilirubin-induced Auditory Toxicity in Infants with Severe Jaundice$77,000
R03 · FY2009 · HD · contact PI
Bilirubin-induced Auditory Neuropathy in Preterms$191,600
K23 · FY2008 · DC · contact PI
Bilirubin-induced Auditory Neuropathy in Preterms$191,600
K23 · FY2007 · DC · contact PI
Bilirubin-induced Auditory Neuropathy in Preterms$191,600
K23 · FY2006 · DC · contact PI
Bilirubin-induced Auditory Neuropathy in Preterms$98,965
K23 · FY2005 · DC
Bilirubin-induced Auditory Neuropathy in Preterms$98,488
K23 · FY2005 · DC
Bilirubin-induced Auditory Neuropathy in Preterms$193,312
K23 · FY2004 · DC
STEROID INDUCED LIPID INTOLERANCE$19,613
M01 · FY2001 · RR